Nafazatrom
Nafazatrom is a pyrazolinone-derived lipoxygenase inhibitor that elevates endogenous prostacyclin (PGI2) levels, exhibiting antithrombotic effects and experimental anticancer activity. It has been studied in research models for its role in reducing arrhythmias following cardiac injury and in modulating eicosanoid pathways in vitro.
Product Specifications
CAS Number
59040-30-1
Field of Research
Metabolism Research
Smiles
O (CCN1N=C (C) CC1=O) C2=CC3=C (C=C2) C=CC=C3
Molecular Formula
C16H16N2O2
Molecular Weight
268.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog